Curis | CRIS - Ebitda





Ebitda تغيير تاريخ
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Amgen USD 5.8B 1.25B 2026-09
AstraZeneca USD 7.46B 2.3B 2026-09
Bayer EUR 1.62B 529M 2026-09
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
CSL USD 3.13B 1.17B 2025-12
Curis USD -12.3M 231K 2023-09
Eli Lilly USD 9.46B 3.54B 2026-09
Exelixis USD 275.36M 19.96M 2026-09
Gilead Sciences USD -9.31B 12.82B 2026-06
GlaxoSmithKline GBP 3.51B 734M 2026-06
Incyte USD 778.57M 410.6M 2026-06
Merck USD 1.42B 2.97B 2026-06
Novartis USD 8.62B 2.14B 2026-09
Pfizer USD 6.36B 350M 2026-09
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 5.79B 2.1B 2026-09
Takeda JPY 369.75B 5.29B 2026-09
TG Therapeutics USD 26.9M 1.21M 2026-06